Mirabella Financial Services LLP Sells 48,768 Shares of Liquidia Corporation $LQDA

Mirabella Financial Services LLP lessened its position in Liquidia Corporation (NASDAQ:LQDA) by 9.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 451,232 shares of the company’s stock after selling 48,768 shares during the period. Mirabella Financial Services LLP’s holdings in Liquidia were worth $5,622,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Quarry LP acquired a new stake in Liquidia in the 1st quarter valued at about $79,000. Steward Partners Investment Advisory LLC raised its stake in Liquidia by 24.0% in the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock valued at $77,000 after buying an additional 1,200 shares during the period. Corsair Capital Management L.P. bought a new stake in Liquidia in the first quarter valued at approximately $148,000. Blueshift Asset Management LLC acquired a new stake in shares of Liquidia in the second quarter valued at approximately $127,000. Finally, Aigen Investment Management LP bought a new position in shares of Liquidia during the 1st quarter worth approximately $151,000. 64.54% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on LQDA shares. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $45.00 price objective on shares of Liquidia in a report on Monday, November 3rd. BTIG Research reissued a “buy” rating and issued a $49.00 price objective on shares of Liquidia in a research report on Tuesday, November 4th. Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Wednesday, October 8th. Finally, Raymond James Financial reiterated a “strong-buy” rating and issued a $47.00 price target on shares of Liquidia in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $38.56.

Insider Activity at Liquidia

In other Liquidia news, insider Rajeev Saggar sold 71,381 shares of Liquidia stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $27.00, for a total value of $1,927,287.00. Following the completion of the transaction, the insider directly owned 176,549 shares of the company’s stock, valued at $4,766,823. The trade was a 28.79% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael Kaseta sold 11,630 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $23.41, for a total value of $272,258.30. Following the completion of the transaction, the chief financial officer owned 352,646 shares in the company, valued at $8,255,442.86. The trade was a 3.19% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 215,168 shares of company stock valued at $5,675,425. 26.50% of the stock is currently owned by company insiders.

Liquidia Stock Up 0.5%

LQDA opened at $33.92 on Friday. The stock has a fifty day moving average of $26.04 and a 200-day moving average of $21.73. The company has a market capitalization of $2.95 billion, a P/E ratio of -23.56 and a beta of 0.48. Liquidia Corporation has a fifty-two week low of $10.37 and a fifty-two week high of $34.08. The company has a debt-to-equity ratio of 6.19, a quick ratio of 1.96 and a current ratio of 2.20.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, November 3rd. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.45) by $0.41. Liquidia had a negative net margin of 176.04% and a negative return on equity of 296.78%. The business had revenue of $54.34 million for the quarter, compared to analyst estimates of $18.86 million. Liquidia’s quarterly revenue was up 1106.7% on a year-over-year basis. On average, equities analysts expect that Liquidia Corporation will post -1.51 EPS for the current year.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).